Ilex Medical Asset Resilience Ratio
Ilex Medical asset resilience ratio. Ilex Medical (ILX) has an Asset Resilience Ratio of 3.49% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ILX current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ilex Medical (2008–2025)
Asset resilience ratio of Ilex Medical from 2008 to 2025. This chart shows how Ilex Medical's Asset Resilience Ratio has changed over time. See cash generation quality of Ilex Medical to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Ilex Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Ilex Medical assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA33.37 Million | 3.49% |
| Total Liquid Assets | ILA33.37 Million | 3.49% |
Asset Resilience Insights
- Limited Liquidity: Ilex Medical maintains only 3.49% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ilex Medical Industry Peers by Asset Resilience Ratio
Compare Ilex Medical's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
TELES Informationstechnologien AG
XETRA:TLIK |
Medical Distribution | 0.37% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 3.91% |
Ilex Medical Asset Resilience Ratio by Year (2008–2025)
Ilex Medical asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Ilex Medical.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.65% | ILA56.05 Million ≈ $150.26K |
ILA992.74 Million ≈ $2.66 Million |
-0.03pp |
| 2024-12-31 | 5.67% | ILA56.38 Million ≈ $151.14K |
ILA994.07 Million ≈ $2.67 Million |
-0.71pp |
| 2023-12-31 | 6.39% | ILA64.88 Million ≈ $173.94K |
ILA1.02 Billion ≈ $2.72 Million |
+3.80pp |
| 2022-12-31 | 2.59% | ILA23.24 Million ≈ $62.32K |
ILA899.18 Million ≈ $2.41 Million |
-0.12pp |
| 2021-12-31 | 2.71% | ILA23.71 Million ≈ $63.56K |
ILA875.07 Million ≈ $2.35 Million |
+0.92pp |
| 2020-12-31 | 1.79% | ILA13.92 Million ≈ $37.32K |
ILA779.25 Million ≈ $2.09 Million |
-4.50pp |
| 2019-12-31 | 6.28% | ILA36.56 Million ≈ $98.03K |
ILA581.85 Million ≈ $1.56 Million |
+0.00pp |
| 2018-12-31 | 6.28% | ILA33.51 Million ≈ $89.84K |
ILA533.38 Million ≈ $1.43 Million |
-0.84pp |
| 2017-12-31 | 7.12% | ILA34.54 Million ≈ $92.60K |
ILA484.92 Million ≈ $1.30 Million |
+0.50pp |
| 2016-12-31 | 6.62% | ILA32.27 Million ≈ $86.53K |
ILA487.56 Million ≈ $1.31 Million |
+0.11pp |
| 2015-12-31 | 6.51% | ILA31.35 Million ≈ $84.04K |
ILA481.60 Million ≈ $1.29 Million |
+0.52pp |
| 2014-12-31 | 5.99% | ILA30.33 Million ≈ $81.31K |
ILA506.54 Million ≈ $1.36 Million |
-3.36pp |
| 2013-12-31 | 9.35% | ILA49.96 Million ≈ $133.95K |
ILA534.54 Million ≈ $1.43 Million |
-1.37pp |
| 2012-12-31 | 10.72% | ILA64.38 Million ≈ $172.59K |
ILA600.69 Million ≈ $1.61 Million |
+8.22pp |
| 2011-12-31 | 2.50% | ILA17.18 Million ≈ $46.05K |
ILA687.23 Million ≈ $1.84 Million |
-9.63pp |
| 2010-12-31 | 12.13% | ILA23.24 Million ≈ $62.31K |
ILA191.62 Million ≈ $513.72K |
+3.91pp |
| 2009-12-31 | 8.22% | ILA15.86 Million ≈ $42.52K |
ILA192.91 Million ≈ $517.19K |
+1.62pp |
| 2008-12-31 | 6.60% | ILA11.23 Million ≈ $30.10K |
ILA170.14 Million ≈ $456.13K |
-- |
About Ilex Medical
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information manageme… Read more